Financials
- Market Capitalization 495.63 M
- Employee 246
- Founded 2013
- CEO N/A
- Website www.arvinas.com
- Headquarter Delaware, United States
- FIGI BBG00LW7YK82
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-10.4
Fiyat/satışlar oranı
3.2
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2847 | ALT Altimmune, Inc. - Common Stock | 2.58 USD | -1.15% | -3.37% | -21.10% | -34.18% | 501.86 M USD | ||
| 2852 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.40 USD | -4.11% | -4.76% | -21.79% | +6.06% | 483.69 M USD | ||
| 2881 | YDES YD Bio Limited - Ordinary Shares | 6.79 USD | +0.89% | -5.56% | +69.33% | -61.44% | 480.66 M USD | ||
| 2887 | OVID Ovid Therapeutics Inc. - Common Stock | 2.44 USD | -0.81% | +3.83% | -10.29% | +41.86% | 476.53 M USD |